 |
 |
|
 |
|
Accession |
Disease |
Description |
Year |
Source |
RNA-Seq |
Count |
Biomarkers |
|
GSE119291 |
Schizophrenia |
Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [MSA102] |
2018 |
Cell line |
N |
5718 |
 |
|
GSE25219 |
Brain |
Spatio-temporal transcriptome of the human brain |
2010 |
Tissue |
N |
2680 |
|
|
GSE84422 |
Alzheimer's disease |
Molecular Signatures Underlying Selective Regional Vulnerability to Alzheimer's Disease |
2016 |
Tissue |
N |
2004 |
|
|
GSE60862 |
Brain |
Gene-level analysis of 1231 samples originating from 134 Caucasian individuals |
2014 |
Tissue |
N |
1231 |
|
|
GSE60863 |
Brain |
Exon-level analysis of 1231 samples originating from 134 Caucasian individuals |
2014 |
Tissue |
N |
1231 |
|
|
GSE112681 |
ALS |
Whole blood transcriptome analysis in amyotrophic lateral sclerosis: a biomarker study |
2018 |
Blood |
N |
1117 |
|
|
GSE41850 |
Multiple Sclerosis |
Longitudinal expression profiling in whole blood of multiple sclerosis patients and controls |
2012 |
Blood |
N |
815 |
 |
|
GSE112676 |
ALS |
Whole blood transcriptome analysis in amyotrophic lateral sclerosis: a biomarker study [HT12_V3] |
2018 |
Blood |
N |
741 |
|
|
GSE127711 |
Brain |
Blood Biomarkers for Memory: Towards Early Detection of Risk for Alzheimer Disease, Pharmacogenomics, and Repurposed Drugs |
2019 |
Blood |
N |
734 |
|
|
GSE140829 |
Alzheimer's disease |
Systems-level analysis of peripheral blood gene expression in dementia patients reveals an innate immune response shared across multiple disorders [ad_mci] |
2019 |
Blood |
N |
587 |
 |
|
GSE99039 |
Parkinson's disease |
A blood-based gene signature characterizing Idiopathic Parkinson's disease |
2017 |
Blood |
N |
558 |
|
|
GSE140830 |
Alzheimer's disease |
Systems-level analysis of peripheral blood gene expression in dementia patients reveals an innate immune response shared across multiple disorders [ftd] |
2019 |
Blood |
N |
542 |
|
|
GSE37772 |
Autism |
Genome-wide transcriptome profiling reveals the functional impact of rare de novo and recurrent CNVs in autism spectrum disorders |
2012 |
Cell line |
N |
439 |
|
|
GSE138525 |
Autism |
Pluripotent stem cell derived models of neurological diseases reveal early transcriptional heterogeneity |
2019 |
Cell line |
Y |
426 |
|
|
GSE118553 |
Alzheimer's disease |
Transcriptomic analysis of probable asymptomatic and symptomatic Alzheimer Brains |
2018 |
Tissue |
Y |
401 |
|
|
GSE63061 |
Alzheimer's disease |
Alzheimer, Mild Cognitive impairment and control samples from AddneuroMed Cohort (batch 2) |
2014 |
Blood |
N |
388 |
|
|
GSE119276 |
Schizophrenia |
Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [MSA102] |
2018 |
Cell line |
N |
379 |
|
|
GSE112680 |
ALS |
Whole blood transcriptome analysis in amyotrophic lateral sclerosis: a biomarker study [HT12_V4] |
2018 |
Blood |
N |
376 |
|
|
GSE119275 |
Schizophrenia |
Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [MSA101] |
2018 |
Cell line |
N |
374 |
|
|
GSE63060 |
Alzheimer's disease |
Alzheimer, Mild Cognitive impairment and control samples from AddneuroMed Cohort |
2014 |
Blood |
N |
329 |
|
|
GSE63063 |
Alzheimer's disease |
Alzheimer, Mild Cognitive impairment and control samples from AddneuroMed Cohort |
2014 |
Blood |
N |
329 |
|
|
GSE125583 |
Alzheimer's disease |
RNA Expression in fusiform gyrus of AD and Control subjects |
2019 |
Tissue |
Y |
289 |
|
|
GSE18123 |
Autism |
Blood gene expression signatures distinguish autism spectrum disorders from controls |
2009 |
Blood |
N |
285 |
|
|
GSE48350 |
Alzheimer's disease |
Alzheimer's Disease Dataset |
2013 |
Tissue |
N |
253 |
|
|
GSE68850 |
Glioblastoma Multiform |
caArray_gabri-00003: TCGA Analysis of RNA Expression for Glioblastoma Multiforme |
2015 |
Tissue |
N |
228 |
|
|
GSE123302 |
Autism |
A meta-analysis of two high-risk prospective studies reveals autism-specific transcriptional changes to chromatin, autoimmune, and environmental response genes in umbilical cord blood |
2018 |
Blood |
N |
224 |
|
|
GSE131617 |
Alzheimer's disease |
Genes associated with the progression of neurofibrillary tangles in Alzheimer's disease |
2019 |
Tissue |
N |
213 |
|
|
GSE41847 |
Multiple Sclerosis |
Longitudinal expression profiling in whole blood of multiple sclerosis patients and controls [IFN_replication dataset] |
2012 |
Blood |
N |
183 |
|
|
GSE73038 |
Brain |
Gene expression data from CNS-PNETs and various other brain tumor samples |
2015 |
Tissue |
N |
182 |
|
|
GSE85426 |
Alzheimer's disease |
Peripheral blood gene expression as a biomarker for early detection of Alzheimer’s disease |
2016 |
Blood |
N |
180 |
|
|
GSE68527 |
Multiple Sclerosis |
Gene expression studies of a human monocyte cell line identify dissimilarities between Copaxone and Probioglat (MS patients) |
2015 |
Blood |
N |
178 |
|
|
GSE11882 |
Brain |
Gene expression changes in the course of normal brain aging are sexually dimorphic |
2008 |
Tissue |
N |
173 |
|
|
GSE35977 |
Mental disorders |
Expression data from the human parietal cortex brain |
2012 |
Tissue |
N |
168 |
|
|
GSE153104 |
Alzheimer's disease |
Transcriptomic analysis of PBMC, CD4 memory and CD8 memory T cells in Alzheimer's disease patients and age-matched controls |
2020 |
Blood |
Y |
166 |
|
|
GSE5281 |
Alzheimer's disease |
Alzheimer's disease and the normal aged brain (steph-affy-human-433773) |
2006 |
Tissue |
N |
161 |
|
|
GSE111176 |
Autism |
Transcriptional organization of autism spectrum disorder |
2018 |
Blood |
N |
147 |
|
|
GSE25507 |
Autism |
Autism and increased paternal age related changes in global levels of gene expression regulation |
2010 |
Blood |
N |
146 |
|
|
GSE19285 |
Multiple Sclerosis |
Expression data of multiple sclerosis patients receiving intramuscular Interferon-beta-1a therapy [U133 A and B] |
2009 |
Blood |
N |
144 |
|
|
GSE17048 |
Multiple Sclerosis |
Multiple Sclerosis Blood Cell mRNA Transcriptome |
2009 |
Blood |
N |
144 |
|
|
GSE57475 |
Parkinson's disease |
Association between alpha-synuclein blood transcripts and early Parkinson's disease |
2014 |
Blood |
N |
142 |
|
|
GSE61374 |
Brain |
Expression data from cerebral tumors of WHO grade II and III |
2014 |
Tissue |
N |
137 |
|
|
GSE122063 |
Alzheimer's disease |
Dementia Comparison: VaD vs. AD vs. Controls |
2018 |
Tissue |
N |
136 |
|
|
GSE26927 |
Alzheimer's disease |
Common neuroinflammatory pathways in neurodegenerative diseases |
2011 |
Tissue |
N |
118 |
|
|
GSE95587 |
Alzheimer's disease |
Heterogeneity in neurodegenerative disease |
2017 |
Tissue |
Y |
117 |
|
|
GSE73129 |
Schizophrenia |
Molecular signatures associated with cognitive deficits in schizophrenia: a study of biopsied olfactory neural epithelium |
2015 |
Tissue/Blood |
N |
115 |
|
|
GSE28894 |
Parkinson's disease |
Gene expression changes across multiple regions of the Parkinson’s disease brain |
2011 |
Tissue |
N |
114 |
|
|
GSE6613 |
Parkinson's disease |
Parkinson's disease vs. controls, whole blood |
2006 |
Blood |
N |
105 |
|
|
GSE87847 |
Autism |
A Putative Blood-Based Biomarker for Autism Spectrum Disorder-Associated Ileocolitis |
2016 |
Tissue |
N |
93 |
|
|
GSE62191 |
Schizophrenia |
Gene expression profiles of patients with schizophrenia, bipolar disorder and healthy controls |
2014 |
Tissue |
N |
88 |
|
|
E-TABM-940 |
ALS |
Transcription profiling of human blood from patients with ALS vs healthy |
2010 |
Blood |
N |
85 |
|
|
GSE146383 |
Multiple Sclerosis |
Effect of Age on Severity and Recovery of Acute Multiple Sclerosis Attack |
2020 |
Blood |
N |
85 |
|
|
GSE26415 |
Autism |
Autism-associated gene expression signatures in peripheral blood leucocytes |
2011 |
Blood |
N |
84 |
|
|
GSE28521 |
Autism |
Transcriptomic Analysis of Autism Brain Reveals Convergent Molecular Pathology [array data] |
2011 |
Tissue |
N |
79 |
|
|
GSE36980 |
Alzheimer's disease |
Expression data from post mortem Alzheimer's disease brains |
2012 |
Tissue |
N |
78 |
|
|
GSE68607 |
ALS |
C9ORF72 GGGGCC expanded repeats produce splicing dysregulation which correlates with disease severity in amyotrophic lateral sclerosis [HuEx-1_0-st] |
2015 |
Tissue |
N |
69 |
|
|
GSE122438 |
Alzheimer's disease |
Curcumin and novel synthetic analogs in Alzheimer’s disease prevention |
2018 |
Blood |
Y |
69 |
|
|
GSE109905 |
Autism |
Genome-wide DNA methylation analysis in autism spectrum disorders (ASD patients vs Controls) |
2018 |
Blood |
N |
69 |
|
|
GSE74187 |
Glioblastoma Multiform |
Sixty Glioblastoma Multiforme (GBM) samples obtained from surgical excision with OS and PFS |
2015 |
Tissue |
N |
60 |
|
|
GSE62584 |
Multiple Sclerosis |
PBMC gene expression of early onset of the first demyelinating event of acute optic neuritis |
2014 |
Blood |
N |
60 |
|
|
GSE65106 |
Autism |
Expression profiling of skin fibroblast, iPSC, iPSC-derived neural progenitors, and iPSC-derived neurons from Autism Spectrum Disorder male patients and their unaffected normal male siblings |
2015 |
Tissue |
N |
59 |
|
|
GSE6575 |
Autism |
Gene expression in blood of children with autism spectrum disorder |
2006 |
Blood |
N |
56 |
|
|
GSE123496 |
Multiple Sclerosis |
Human brain tissues from healthy controls and multiple sclerosis patients |
2018 |
Tissue |
Y |
50 |
|
|
GSE8397 |
Parkinson's disease |
Expression profiling of the Parkinsonian Brain |
2007 |
Tissue |
N |
47 |
|
|
GSE119290 |
Schizophrenia |
Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [RNA-seq] |
2018 |
Cell line |
Y |
44 |
|
|
GSE150696 |
Alzheimer's disease |
Transcriptome profiling of prefrontal cortex (BA9) in neurodegenerative dementia using Affymetrix Human Transcriptome Array 2.0 |
2020 |
Tissue |
N |
42 |
|
|
GSE53890 |
Alzheimer's disease |
REST and Stress Resistance in Aging and Alzheimer’s Disease |
2014 |
Tissue |
N |
41 |
|
|
E-MTAB-6094 |
Alzheimer's disease |
Whole genome transcriptional analysis of Alzheimer's disease patients compared with age-matched non-demented controls |
2017 |
Blood |
N |
35 |
|
|
GSE9770 |
Alzheimer's disease |
Non-demented individuals with intermediate Alzheimer's neuropathologies - neuronal expression (6 regions) |
2007 |
Tissue |
N |
34 |
|
|
GSE76826 |
Depression |
Blood transcriptomic markers in patients with late-onset major depressive disorder |
2016 |
Blood |
N |
32 |
|
|
GSE1297 |
Alzheimer's disease |
Incipient Alzheimer's Disease: Microarray Correlation Analyses |
2004 |
Tissue |
N |
31 |
|
|
GSE29680 |
Alzheimer's disease |
Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study |
2011 |
Blood |
N |
31 |
|
|
GSE28146 |
Alzheimer's disease |
Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer’s disease |
2011 |
Tissue |
N |
30 |
|
|
GSE21942 |
Multiple Sclerosis |
Expression data from peripheral blood mononuclear cells in multiple sclerosis patients and controls |
2010 |
Blood |
N |
29 |
|
|
GSE130494 |
Multiple Sclerosis |
Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis is linked with monocytic oxidative responses |
2019 |
Blood |
N |
28 |
|
|
GSE23676 |
Parkinson's disease |
Expression data from advanced Parkinson's disease (PD) patients leukocytes - prior to and following deep brain stimulation (DBS) treatment in on and off stimulation conditions, and matched healthy control (HC) subjects |
2010 |
Blood |
N |
27 |
|
|
GSE77668 |
Parkinson's disease |
Expression mRNA and miRNA data from human postmortem putamen samples measured using the NanoString nCounter platform |
2016 |
Tissue |
N |
24 |
|
|
GSE77666 |
Parkinson's disease |
Expression mRNA data from human postmortem putamen samples measured using the NanoString nCounter platform |
2016 |
Tissue |
Y |
24 |
|
|
GSE161199 |
Alzheimer's disease |
Alzheimer’s, Parkinson’s disease and Amyotrophic Lateral Sclerosis gene expression patterns divergence reveals different grade of RNA metabolism involvement |
2020 |
Blood |
Y |
23 |
|
|
GSE39420 |
Alzheimer's disease |
Gene expression profile of sporadic and PSEN1 early-onset Alzheimer’s Disease |
2012 |
Tissue |
N |
21 |
|
|
GSE4757 |
Alzheimer's disease |
Alzheimer’s disease: neurofibrillary tangles |
2006 |
Tissue |
N |
20 |
|
|
GSE43592 |
Multiple Sclerosis |
MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS) |
2013 |
Blood |
N |
20 |
|
|
GSE168831 |
ALS |
Comparison of the whole transcriptomes between ALS-mutant and Healthy control motor neurons |
2021 |
Tissue |
Y |
18 |
|
|
GSE53697 |
Alzheimer's disease |
RNAseq in Alzheimer's Disease patients |
2013 |
Tissue |
Y |
17 |
|
|
GSE12685 |
Alzheimer's disease |
Expression of mRNAs Regulating Synaptic Function and Neuroplasticity in Incipient AD |
2008 |
Tissue |
N |
14 |
|
|
GSE123021 |
Alzheimer's disease |
Bulk RNA-seq of adult homeostatic microglia from 4 brain regions |
2018 |
Tissue |
Y |
12 |
|
|
GSE78703 |
Brain |
Pharmacological Targeting of a Metabolic Co-Dependency Pathway in Brain Cancers |
2016 |
Tissue |
N |
12 |
|
|
GSE68605 |
ALS |
C9ORF72 GGGGCC expanded repeats produce splicing dysregulation which correlates with disease severity in amyotrophic lateral sclerosis [HG-U133_Plus_2] |
2015 |
Tissue |
N |
11 |
|
|
GSE18309 |
Alzheimer's disease |
Transcriptomes in Peripheral Blood Mononuclear Cells of Dementia and Alzheimer Patients |
2009 |
Blood |
N |
9 |
|
|
GSE16759 |
Alzheimer's disease |
mRNA and miRNA expression in parietal lobe cortex in Alzheimer's disease |
2009 |
Tissue |
N |
8 |
|
|
GSE77103 |
Autism |
Gene expression in peripheral blood mononuclear cells from healthy control and autistic infants |
2016 |
Blood |
N |
8 |
|
|
|
|
|
|
|
|
|